NovaBay Pharmaceuticals, Inc. (NBY) Social Stream
NOVABAY PHARMACEUTICALS INC (NBY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NBY.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 11, 2023
The Trend in the Analyst Price Target
NBY's average price target has moved up $1.3 over the prior 34 months.
NBY reports an average of 1,570.78% for its upside potential over the past 36 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
NBY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 39 weeks, NBY's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- NOVABAY PHARMACEUTICALS INC's number of analysts covering the stock is higher than practically none of all US stocks.
- In terms of how NOVABAY PHARMACEUTICALS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 681.15% of that group.
- In the context of Pharmaceutical Products stocks, NOVABAY PHARMACEUTICALS INC's average analyst price target is higher than 188.53% of them.
- NBY has a lower variance in analysts' estimates than -227.53% of stocks in the micro market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NOVABAY PHARMACEUTICALS INC are SNOA, OCUP, and OGEN.
Is NBY a Buy, Hold or Sell? See the POWR Ratings now!